July 10, 2018
Rose
Meanwhile, HHS Secretary Alex Azar also promised change was coming to the industry "whether it’s painful or not for pharmaceutical companies." But the daunting reality of overhauling the drug pricing system may stand in the way of that message.
from Kaiser Health News https://ift.tt/2u7sUnF
July 10, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
The Time Has Come for DIY Mandates on Covid- Music Festivals Embrace Overdose Reversal Drugs, but Fentanyl Testing Kits Remain Taboo
- To Retain Nurses and Other Staffers, Hospitals Are Opening Child Care Centers
- They Lost Medicaid When Paperwork Was Sent to an Empty Field, Signaling the Mess to Come
- ‘An Arm and a Leg’: Her Bill for a Prenatal Test Felt Like a ‘Bait-and-Switch’ Scheme
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment